Abbott Laboratories announced a plan to invest $500 million to expand its U.S. manufacturing footprint. The medical device maker will upgrade facilities in both Illinois and Texas to expand its ...

Is now the time to buy Abbott Laboratories? Find out in our full research report. Adjusted EPS guidance for the full year is $5.15 at the midpoint, roughly in line with what analysts were ...

What Happened? Shares of healthcare product and device company Abbott Laboratories (NYSE:ABT) jumped 5.4% in the morning ...

Abbott Laboratories will make new investments in ... First-quarter sales were $10.4 billion, in line with Wall Street’s estimate. Medical device sales were $4.9 billion, compared to the average ...

Q1 2025 Earnings Conference Call April 16, 2025 9:00 AM ETCompany ParticipantsMike Comilla - VP, IRRobert Ford - Chairman ...

currency hit Abbott Laboratories on Wednesday forecast 2025 profit that came in line with Wall Street estimates as it expects new device launches and growing demand for its glucose monitors to ...

Abbott Laboratories will make new investments in ... First-quarter sales were $10.4 billion, in line with Wall Street’s estimate. Medical device sales were $4.9 billion, compared to the average ...